Long-Term Treatment Duration and Safety of Axatilimab Among Patients with Chronic Graft-Versus-Host Disease in AGAVE-201

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Carrie L. Kitko, Amandeep Salhotra, Mi Kwon, Zhenyi Xue, Valkal Bhatt, John Galvin, Patrick Hardesty, Silvia Mosher, Daniel Wolff
DOI: 10.1016/j.jtct.2025.12.378
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Immunodeficiency and Autoimmune Disorders Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S265–S266
Publication date
1 February 2026
Language
EN